Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382(10):937–50. https://doi.org/10.1056/NEJMra1810772.
Article CAS PubMed Google Scholar
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10(11):804–26. https://doi.org/10.1016/S2213-8587(22)00244-3.
Article CAS PubMed Google Scholar
Burton T, Le Nestour E, Neary M, Ludlam WH. Incidence and prevalence of acromegaly in a large US health plan database. Pituitary. 2016;19(3):262–7. https://doi.org/10.1007/s11102-015-0701-2.
Article PubMed PubMed Central Google Scholar
Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G, Ferraù F, Gianfrilli D, Cozzolino A, Cristina De Martino M, Gatto F, Barone-Adesi F, Cannavò S, Trifirò G. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(2):251–63. https://doi.org/10.1530/EJE-21-0216.
Article CAS PubMed Google Scholar
Matsubayashi K, Kawakami K. Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database. Endocr J. 2020;67(10):997–1006. https://doi.org/10.1507/endocrj.EJ20-0129.
Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4–9. https://doi.org/10.1007/s11102-016-0754-x.
Park KH, Lee EJ, Seo GH, Ku CR. Risk for Acromegaly-related Comorbidities by Sex in Korean Acromegaly. J Clin Endocrinol Metab. 2020;105(4):dgz17. https://doi.org/10.1210/clinem/dgz317.
Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS. Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol. 2018;179(1):59–71. https://doi.org/10.1530/EJE-18-0255.
Article CAS PubMed Google Scholar
Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004;89(2):667–74. https://doi.org/10.1210/jc.2003-031199.
Article CAS PubMed Google Scholar
Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, JohannssonBeckers GA, Fleseriu M, Giustina A, Wass JAH, Ho KKY. Clinical biology of the pituitary adenoma. Endocr Rev. 2022;43(6):1003–37. https://doi.org/10.1210/endrev/bnac010.
Article PubMed PubMed Central Google Scholar
Ritvonen E, Löyttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P, Kauppinen-Mäkelin R, Schalin-Jäntti C. Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer. 2016;23(6):469–80. https://doi.org/10.1530/ERC-16-0106.
Article CAS PubMed Google Scholar
Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S; Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024 Feb;27(1):7–22. https://doi.org/10.1007/s11102-023-01360-1. Epub 2023 Nov 3. Erratum in: Pituitary. 2024 Feb;27(1):88. https://doi.org/10.1007/s11102-023-01373-w.
Amodru V, Sahakian N, Piazzola C, Appay R, Graillon T, Cuny T, Morange I, Albarel F, Vermalle M, Regis J, Dufour H, Brue T, Castinetti F. Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades. Pituitary. 2024;27(3):294–302. https://doi.org/10.1007/s11102-024-01387-y.
Article CAS PubMed Google Scholar
Gadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocr Rev. 2019;40(1):268–332. https://doi.org/10.1210/er.2018-00115.
Ghajar A, Jones PS, Guarda FJ, Faje A, Tritos NA, Miller KK, Swearingen B, Nachtigall LB. Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time. J Clin Endocrinol Metab. 2020;105(3):e532–43. https://doi.org/10.1210/clinem/dgz187.
Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A. Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab. 2008;93(6):2035–41. https://doi.org/10.1210/jc.2007-2149.
Article CAS PubMed Google Scholar
Ioachimescu AG, Handa T, Goswami N, Pappy AL 2nd, Veledar E, Oyesiku NM. Gender differences and temporal trends over two decades in acromegaly: a single center study in 112 patients. Endocrine. 2020;67(2):423–32. https://doi.org/10.1007/s12020-019-02123-4.
Article CAS PubMed Google Scholar
Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346–53. https://doi.org/10.1016/S0140-6736(04)16044-3.
Article CAS PubMed Google Scholar
Danilowicz K, Sosa S. Acromegaly and cancer: an update. Arch Med Res. 2023;54(8): 102914. https://doi.org/10.1016/j.arcmed.2023.102914.
Article CAS PubMed Google Scholar
Freda PU, Bruce JN, Jin Z, Kostadinov J, Khandji AG, Cremers S, Post KD. Prospective, longitudinal study of cancer predictors and rates in a New York City cohort of 598 patients with acromegaly. J Clin Endocrinol Metab. 2024;10:dgae469. https://doi.org/10.1210/clinem/dgae469.
Petroff D, Tönjes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hancke C, Mai M, Schopohl J, Schöfl C. The incidence of cancer among acromegaly patients: results from the German acromegaly registry. J Clin Endocrinol Metab. 2015;100(10):3894–902. https://doi.org/10.1210/jc.2015-2372.
Article CAS PubMed Google Scholar
Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol. 2004;151(4):439–46. https://doi.org/10.1530/eje.0.1510439.
Article CAS PubMed Google Scholar
Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, François P, Bertherat J, Cortet-Rudelli C, Chanson P, French Acromegaly Registry Group. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol. 2017;176(5):645–55. https://doi.org/10.1530/EJE-16-1064.
Article CAS PubMed Google Scholar
Guevara-Aguirre J, Peña G, Acosta W, Pazmiño G, Saavedra J, Soto L, Lescano D, Guevara A, Gavilanes AWD. Cancer in growth hormone excess and growth hormone deficit. Endocr Relat Cancer. 2023;30(10): e220402. https://doi.org/10.1530/ERC-22-0402.
Article CAS PubMed Google Scholar
Melmed S. Acromegaly and cancer: not a problem? J Clin Endocrinol Metab. 2001;86(7):2929–34. https://doi.org/10.1210/jcem.86.7.7635.
Article CAS PubMed Google Scholar
Maione L, Chanson P. National acromegaly registries. Best Pract Res Clin Endocrinol Metab. 2019;33(2): 101264. https://doi.org/10.1016/j.beem.2019.02.001.
Găloiu S, Toma ID, Tănasie DI, Bărbulescu A, Baciu I, Niculescu DA, Trifănescu RA, Căpăţînă C, Radian Ş, Poiană C. High mortality risk among women with acromegaly still persists. Front Endocrinol (Lausanne). 2024;21(15):1348972. https://doi.org/10.3389/fendo.2024.1348972.
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020;21(4):667–78. https://doi.org/10.1007/s11154-020-09588-z.
Article PubMed PubMed Central Google Scholar
Brue T, Rahabi H, Barry A, Barlier A, Bertherat J, Borson-Chazot F, Castinetti F, Cazabat L, Chabre O, Chevalier N, Christin-Maitre S, Cortet
Comments (0)